Prospective pharmacologic therapies for the overactive bladder
- 21 May 2009
- journal article
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 1 (2) , 71-83
Abstract
Lower urinary tract symptoms (LUTS), overactive bladder syndrome (OAB) and detrusor overactivity (DO) are all conditions that can have major effects on quality of life and social functioning. Antimuscarinic drugs are first-line treatment-they often have good initial response rates, but adverse effects and decreasing efficacy cause long-term compliance problems, and alternatives are needed. The recognition of the functional contribution of the urothelium, the spontaneous myocyte activity during bladder filling, and the diversity of nerve transmitters has sparked interest in both peripheral and central modulation of LUTS/OAB/DO pathophysiology. There may be several new possibilities to treat LUTS/OAB/DO. β3-AR agonists (YM178), PDE 5 inhibitors (sildenafil, tadalafil, vardenafil), vitamin D analogs (elocalcitol), combinations (α1-AR antagonist + antimuscarinic), and drugs with a central mode of action (tramadol, aprepitant) all have Randomized controlled trial (RCT) documented efficacy. Which of these therapeutic principles will be developed to clinically useful treatments remains to be established.Keywords
This publication has 104 references indexed in Scilit:
- The neural control of micturitionNature Reviews Neuroscience, 2008
- Gabapentin: A Ca2+ channel alpha2-delta ligand far beyond epilepsy therapyDrugs of Today, 2008
- The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstructionBJU International, 2007
- Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voidingJournal of Clinical Investigation, 2007
- Activation of Urothelial Transient Receptor Potential Vanilloid 4 by 4α-Phorbol 12,13-Didecanoate Contributes to Altered Bladder Reflexes in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Effect of lumbar-epidural administration of tramadol on lower urinary tract functionNeurourology and Urodynamics, 2007
- Mechanisms of Disease: involvement of the urothelium in bladder dysfunctionNature Reviews Endocrinology, 2007
- BXL‐628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladderThe Prostate, 2006
- Micturition and the soulJournal of Comparative Neurology, 2005
- Phosphodiesterase‐linked inhibition of nonmicturition activity in the isolated bladderBJU International, 2004